Dynavax Technologies
DVAX
#5494
Rank
HK$10.01 B
Marketcap
HK$85.32
Share price
-0.09%
Change (1 day)
-14.97%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : HK$2.21 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is HK$2.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$1.97 B-1.56%
2023-12-31HK$2.00 B-0.47%
2022-12-31HK$2.01 B0.45%
2021-12-31HK$2.00 B18.84%
2020-12-31HK$1.68 B0.18%
2019-12-31HK$1.68 B113.4%
2018-12-31HK$0.78 B
2014-12-31HK$74.14 M
2012-12-31N/A-100%
2011-12-31HK$99.49 M8.51%
2010-12-31HK$91.68 M-4.5%
2009-12-31HK$96 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
HK$0.35 B-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$51.30 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$322.08 B 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$194.15 B 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$254.03 B 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
HK$185.75 B 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$473.68 B 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$132.90 B 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$424.94 B 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA